BSH updates guidelines on T-cell lymphomas and NK-cell lymphomas

New guidelines give clear treatment recommendations for people with T-cell and NK-cell lymphomas

BSH British society for haematology logo

The British Society for Haematology (BSH) has updated its guidelines on the management of T-cell and NK-cell lymphomas. These are rare types of non-Hodgkin lymphoma that often have no standard treatment pathway.

The updated guidelines have been developed by specialist haematologists from across the UK. They summarise the main features of the different types of T-cell and NK-cell lymphomas and recommend evidence-based treatment options supported by the most recent clinical trial data. The guidelines aim to make sure people with these rare types of lymphoma get the most appropriate treatment.

Date of Publication: 10 January 2022